Ignite Creation Date:
2025-12-24 @ 11:48 AM
Ignite Modification Date:
2025-12-30 @ 4:32 PM
Study NCT ID:
NCT00276861
Status:
TERMINATED
Last Update Posted:
2017-02-08
First Post:
2006-01-12
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Gemcitabine and Oxaliplatin as Second-Line Therapy in Treating Patients With Metastatic Colon Cancer
Sponsor:
University of Miami
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-09
Start Date Type:
None
Primary Completion Date:
2006-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-05
Completion Date Type:
ACTUAL
First Submit Date:
2006-01-12
First Submit QC Date:
None
Study First Post Date:
2006-01-13
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2013-01-22
Results First Submit QC Date:
None
Results First Post Date:
2013-02-26
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-12-14
Last Update Post Date:
2017-02-08
Last Update Post Date Type:
ESTIMATED